LogicBio Therapeutics (LOGC) Misses Q1 EPS by 27c
Tweet
Share
E-mailGet Alerts LOGC Hot Sheet
Price: $7.06 --0%
EPS Growth %: +42.9%
Financial Fact:
Gross margin: 151.4K
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +42.9%
Financial Fact:
Gross margin: 151.4K
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
LogicBio Therapeutics (NASDAQ: LOGC) reported Q1 EPS of ($0.27).
For earnings history and earnings-related data on LogicBio Therapeutics (LOGC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Shoe Station Group Inc. (SHOE) Tops Q2 EPS by 11c ; Offers Guidance
- Chemours, DuPont and Corteva settle NC PFAS claims for $455M
- Skillsoft (SKIL) Tops Q2 EPS by 14c; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
